Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Banai

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Endoscopy|April 25, 2002
Esophageal intramural metastasis from adenocarcinoma of the gastroesophageal junctionI Szántó, A Vörös, P Nagy, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|September 13, 2020
Subjective expectations regarding longevity and future health: a cross-sectional survey among patients with Crohn's diseaseM Péntek, L Gulácsi, L Herszényi, et al.
Alimentary Pharmacology & Therapeutics|September 3, 2011
Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's diseaseL S Kiss, T Szamosi, T Molnar, et al.
Alimentary Pharmacology & Therapeutics|May 26, 2017
Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrenceW Kruis, V Kardalinos, T Eisenbach, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Endoscopy|April 25, 2002
Esophageal intramural metastasis from adenocarcinoma of the gastroesophageal junctionI Szántó, A Vörös, P Nagy, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|September 13, 2020
Subjective expectations regarding longevity and future health: a cross-sectional survey among patients with Crohn's diseaseM Péntek, L Gulácsi, L Herszényi, et al.
Alimentary Pharmacology & Therapeutics|September 3, 2011
Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's diseaseL S Kiss, T Szamosi, T Molnar, et al.
Alimentary Pharmacology & Therapeutics|May 26, 2017
Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrenceW Kruis, V Kardalinos, T Eisenbach, et al.
Pageof 4